Scientific commentary. Drug absorption and disposition as monitors of safety and efficacy.
D000042:Absorption; D000583:Amikacin / Q000378:metabolism; D000818:Animals; D001682:Biological Availability; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage; D007612:Kanamycin / Q000378:metabolism; D007700:Kinetics; D008991:Monitoring, Physiologic; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D012995:Solubility; D014481:United States; D014486:United States Food and Drug Administration
D006993:Hypnotics and Sedatives; D004364:Pharmaceutical Preparations; D007612:Kanamycin; D000583:Amikacin